Loading…
Improved Access to Osteoporosis Testing Act of 2005
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2005 · year_end · Health Issues
CREATE A NATIONAL ACTION PLAN FOR BONE HEALTH AND OSTEOPOROSIS Provide federal funding through the CDC for the creation of a national action plan for bone health and osteoporosis EXPAND MEDICAL RESEARCH ON OSTEOPOROSIS Increase funding for osteoporosis and related bone diseases at the NIH and DoD EXPAND AND ENSURE HEALTH INSURANCE COVERAGE FOR OSTEOPOROSIS “Medicare Osteoporosis Measurement Act of 2005” (HR 2257) “Osteoporosis Early Detection and Prevention Act of 2005” (HR 2946) “Improved Access to Osteoporosis Testing Act of 2005” (S 1345) Discussions with CMS on the implementation of the ”Medicare Prescription Drug Improvement and Modernization Act of 2003” as it relates to those with or at risk for osteoporosis Comments on the CMS regulations relating to Inpatient Rehabilitation Facilities for those with osteoporotic fractures EXPAND AND ENSURE PREVENTIVE HEALTH CARE SERVICES FOR OSTEOPOROSIS “WISEWOMAN Expansion Act of 2005” (HR 3086) “HELP America Act of 2005” (Section 1509 of S 1074) PROVIDE INFORMATION AND OUTREACH FOR THE PREVENTION AND CARE OF OSTEOPOROSIS “Osteoporosis Education and Prevention Act of 2005” (HR 1081) “National Osteoporosis Awareness and Prevention Month “ (House Res. 265) Discussions with CMS on the implementation of the ”Medicare Prescription Drug Improvement and Modernization Act of 2003” as it relates to those with or at risk for osteoporosis
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $59,189 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2005 · mid_year · Health Issues
CREATE A NATIONAL ACTION PLAN FOR BONE HEALTH AND OSTEOPOROSIS Provide federal funding through the CDC for the creation of a national action plan for bone health and osteoporosis EXPAND MEDICAL RESEARCH ON OSTEOPOROSIS Increase funding for osteoporosis and related bone diseases at the NIH and DoD EXPAND AND ENSURE HEALTH INSURANCE COVERAGE FOR OSTEOPOROSIS “Medicare Osteoporosis Measurement Act of 2005” (HR 2257) “Osteoporosis Early Detection and Prevention Act of 2005” (HR 2946) “Improved Access to Osteoporosis Testing Act of 2005” (S 1345) Discussions with CMS on the implementation of the ”Medicare Prescription Drug Improvement and Modernization Act of 2003” as it relates to those with or at risk for osteoporosis Comments on the CMS regulations relating to Inpatient Rehabilitation Facilities for those with osteoporotic fractures EXPAND AND ENSURE PREVENTIVE HEALTH CARE SERVICES FOR OSTEOPOROSIS “WISEWOMAN Expansion Act of 2005” (HR 3086) “HELP America Act of 2005” (Section 1509 of S 1074) PROVIDE INFORMATION AND OUTREACH FOR THE PREVENTION AND CARE OF OSTEOPOROSIS “Osteoporosis Education and Prevention Act of 2005” (HR 1081) “National Osteoporosis Awareness and Prevention Month “ (House Res. 265) Discussions with CMS on the implementation of the ”Medicare Prescription Drug Improvement and Modernization Act of 2003” as it relates to those with or at risk for osteoporosis
Client expense: $59,189 · Firm income: Not reported
Government targets: Administration on Aging, Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE